Home › Funds › SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI › REGN

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI position in REGN

REGENERON PHARMACEUTICALS · Health Care

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI reported holding 19,810 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$15.0M, representing 0.99% of its reported portfolio and ranking #36 among its reported holdings. SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)19.81K sh
Reported value held$15.02M
Portfolio Weight0.99%
First reportedQ3 2023
Last changeReduce
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI's REGN position evolved

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI first disclosed a stake in REGN in Q3 2023 at 17,949 shares (US$14.8M). The position peaked in Q3 2024 at 18,114 shares, worth US$19.0M. Across 13 filings, SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 19,810 shares valued at US$15.0M — a reduction of -118 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.95K $14.77M New
Q4 2023 17.92K $15.74M Hold
Q1 2024 18.01K $17.33M Hold
Q2 2024 17.93K $18.84M Hold
Q3 2024 18.11K $19.04M Add
Q4 2024 19.33K $13.77M Add
Q1 2025 20.10K $12.75M Add
Q2 2025 22.36K $11.74M Add
Q3 2025 21.73K $12.22M Reduce
Q4 2025 20.52K $15.84M Reduce
Q1 2026 19.85K $15.34M Reduce
Q2 2026 19.93K $12.43M Hold
Q3 2026 19.81K $15.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI held REGN?

SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI's current position in REGN?

As of Q3 2026, SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI holds 19.81K shares of REGN (REGENERON PHARMACEUTICALS), valued at $15.02M, representing 0.99% of its reported portfolio and ranking #36.

Has SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI been buying or selling REGN?

In the latest 13F filing (Q3 2026), SCHAPER BENZ & WISE INVESTMENT COUNSEL INC/WI reduced its position in REGN. The position peaked in Q3 2024 at 18.11K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.